Aicuris: latest news - GoINPHARMA
Wednesday, 17 October 2018 - 3:03


Germany-based Aicuris obtains FDA approval for antiviral

Aicuris is a young pharmaceutical company, established in 2006 as a spin-off of Bayer, headquartered in Wuppertal (Germany), exclusively focusing on developing novel antiviral and antibacterial agents for the treatment of severe infectious diseases. The company this week has reached…

Record year for German biotechs

2016 has brought highly satisfying results to Germany-based biotechs: Morphosys is obtaining very good clinical results. Aicuris (Wuppertal) has convinced many investors with highly positive data on novel antivirals. Ganymed has obtained results so satisfactory from its intestine cancer treatment…